NCT03989206 · Interventional trial
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Moderate-to-Severe Atopic Dermatitis
Delaware Valley sites
- Galderma Investigational Site 8255 · Philadelphia, PA · Philadelphia County
- Galderma Investigational Site 8802 · Plymouth Meeting, PA · Montgomery County
First posted
Registry updated
Added to the directory